Literature DB >> 28283940

In Response to Letter to the Editor Regarding: Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.

Cecilia J Sorensen1, Kristen DeSanto2, Laura Borgelt3, Kristina T Phillips4, Andrew A Monte5,6,7.   

Abstract

Entities:  

Keywords:  Cannabinoid hyperemesis syndrome; Cannabis; Cyclic vomiting syndrome; Haloperidol; Marijuana

Mesh：

Substances：

Year:  2017        PMID： 28283940      PMCID： PMC5440323          DOI： 10.1007/s13181-017-0610-z

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN： 1556-9039


× No keyword cloud information.
  4 in total

1.  Haloperidol, a Novel Treatment for Cannabinoid Hyperemesis Syndrome.

Authors:  Joanne C Witsil; Mark B Mycyk
Journal:  Am J Ther       Date:  2017 Jan/Feb       Impact factor: 2.688

2.  Is haloperidol the wonder drug for cannabinoid hyperemesis syndrome?

Authors:  Faisal Inayat; Hafeez Ul Hassan Virk; Waqas Ullah; Qulsoom Hussain
Journal:  BMJ Case Rep       Date:  2017-01-04

3.  Haloperidol for treatment of cannabinoid hyperemesis syndrome.

Authors:  Jami L Hickey; Joanne C Witsil; Mark B Mycyk
Journal:  Am J Emerg Med       Date:  2013-04-10       Impact factor: 2.469

4.  Successful Treatment of Suspected Cannabinoid Hyperemesis Syndrome Using Haloperidol in the Outpatient Setting.

Authors:  Jennifer L Jones; Karen E Abernathy
Journal:  Case Rep Psychiatry       Date:  2016-08-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.